
PRODUCTS
At Asteri Pharma, our focus is on specialised, complex, and rare-disease therapies—areas where innovation creates real impact and where patients often face limited treatment options. We work closely with clinicians, researchers, and global partners to bring advanced, evidence-based medicines to the ANZ region, with a commitment to timely access, high-quality engagement, and exceptional support for patients, families, and healthcare professionals.
Therapeutic areas
Our growing neurology, endocrinology, cardiology, and oncology portfolio reflects this mission.
Country
Status
Information

Australia
Approved
ISMO®
Isosorbide mononitrate
New Zealand
Approved

Australia
Approved

Approved
Australia
New Zealand
Approved
LYSODREN® mitotane
Australia
New Zealand
Please contact Asteri Pharma for more information
Approved
Australia

